| TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection D Bortolotti, V Gentili, S Rizzo, G Schiuma, S Beltrami, G Strazzabosco, ... Microorganisms 9 (9), 1820, 2021 | 152 | 2021 |
| SARS-CoV-2 spike 1 protein controls natural killer cell activation via the HLA-E/NKG2A pathway D Bortolotti, V Gentili, S Rizzo, A Rotola, R Rizzo Cells 9 (9), 1975, 2020 | 91 | 2020 |
| Innate immune response in SARS-CoV-2 infection G Schiuma, S Beltrami, D Bortolotti, S Rizzo, R Rizzo Microorganisms 10 (3), 501, 2022 | 21 | 2022 |
| Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion D Bortolotti, V Gentili, S Rizzo, G Schiuma, S Beltrami, S Spadaro, ... Viruses 13 (9), 1855, 2021 | 20 | 2021 |
| Relevance of VEGF and CD147 in different SARS‐CoV‐2 positive digestive tracts characterized by thrombotic damage D Bortolotti, C Simioni, LM Neri, R Rizzo, CM Semprini, S Occhionorelli, ... The FASEB Journal 35 (12), e21969, 2021 | 17 | 2021 |
| Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 F Ferrari, S Rizzo, C Ruzza, G Calo Journal of Pharmacology and Experimental Therapeutics 373 (1), 34-43, 2020 | 13 | 2020 |
| Transparent polymeric formulations effective against SARS-CoV-2 infection V Gentili, D Pazzi, S Rizzo, G Schiuma, E Marchini, S Papadia, A Sartorel, ... ACS Applied Materials & Interfaces 13 (46), 54648-54655, 2021 | 11 | 2021 |
| Late‐onset intrauterine growth restriction and HHV‐6 infection: A pilot study D Bortolotti, V Gentili, E Santi, C Taliento, A Vitagliano, G Schiuma, ... Journal of Medical Virology 93 (11), 6317-6322, 2021 | 9 | 2021 |
| Role of KIR receptor in NK regulation during viral infections S Rizzo, G Schiuma, S Beltrami, V Gentili, R Rizzo, D Bortolotti Immuno 1 (3), 305-331, 2021 | 9 | 2021 |
| Effect of SARS-CoV-2 infection in pregnancy on CD147, ACE2 and HLA-G expression G Schiuma, S Beltrami, E Santi, G Scutiero, JM Sanz, CM Semprini, ... Placenta 132, 38-43, 2023 | 5 | 2023 |
| Natural killer cells in SARS-CoV-2-vaccinated subjects with increased effector cytotoxic cd56dim cells and memory-like CD57+ NKG2C+ CD56dim cells V Gentili, D Bortolotti, L Morandi, S Rizzo, G Schiuma, S Beltrami, ... Frontiers in Bioscience-Landmark 28 (7), 156, 2023 | 4 | 2023 |
| Studying the interactions of U24 from HHV-6 in order to further elucidate its potential role in MS KS Pi, D Bortolotti, Y Sang, G Schiuma, S Beltrami, S Rizzo, A Bortoluzzi, ... Viruses 14 (11), 2384, 2022 | 4 | 2022 |
| Humoral and adaptive immune responses to the SARS-CoV-2 vaccine R Rizzo, D Bortolotti, L Morandi, S Rizzo, G Schiuma, S Beltrami, A Papi, ... International Journal of Infectious Diseases 122, 412-414, 2022 | 4 | 2022 |
| Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus V Gentili, G Turrin, P Marchetti, S Rizzo, G Schiuma, S Beltrami, ... Bioorganic chemistry 119, 105518, 2022 | 4 | 2022 |
| Ozonated Oil in Liposome Eyedrops Reduces the Formation of Biofilm, Selection of Antibiotic-Resistant Bacteria, and Adhesion of Bacteria to Human Corneal Cells V Gentili, G Strazzabosco, N Salgari, A Mancini, S Rizzo, S Beltrami, ... International Journal of Molecular Sciences 24 (18), 14078, 2023 | 3 | 2023 |
| Non-classical HLA class I molecules and their potential role in viral infections S Beltrami, S Rizzo, G Strazzabosco, V Gentili, A Alogna, M Narducci, ... Human Immunology, 2023 | 3 | 2023 |
| Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma D Bortolotti, M Corazza, A Rotola, D Bencivelli, G Schiuma, E Danese, ... Clinical and Experimental Medicine 23 (1), 79-85, 2023 | 2 | 2023 |
| Comparison between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye Infections V Gentili, G Strazzabosco, R Spena, S Rizzo, S Beltrami, G Schiuma, ... Current Therapeutic Research, 100740, 2024 | 1 | 2024 |
| In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies M Baroni, S Beltrami, G Schiuma, P Ferraresi, S Rizzo, A Passaro, ... Life 14 (2), 237, 2024 | 1 | 2024 |
| SARS-CoV-2 Systemic Effects: New Clues S Beltrami, S Rizzo, F Caccuri, R Rizzo, D Bortolotti, G Schiuma Microorganisms 11 (5), 1209, 2023 | 1 | 2023 |
